Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Translational Oncology|December 15, 2021
Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancerR Nicolle, O Gayet, M Bigonnet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 5, 2014
Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): a retrospective review of 114 patients from the French sarcoma group (FSG)F Duffaud, P Meeus, J B Bachet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 14, 2018
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter studyJ B Bachet, O Bouché, J Taieb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2024
Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinomaN Fraunhoffer, P Hammel, T Conroy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2011
New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panelJ-L Van Laethem, C Verslype, J L Iovanna, et al.
The British Journal of Surgery|June 12, 2019
BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastasesJ-B Bachet, N Moreno-Lopez, L Vigano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2020
A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinomaR Nicolle, O Gayet, P Duconseil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 25, 2018
Colorectal cancer (CRC) monitoring by 6-monthly 18FDG-PET/CT: an open-label multicentre randomised trialI Sobhani, E Itti, A Luciani, et al.
Pageof 4